News
Article
Columbia Laboratories Acquires Molecular Profiles
Author(s):
Columbia Laboratories acquires Molecular Profiles in multimillion-dollar deal.
Columbia Laboratories has acquired Molecular Profiles, a UK-based pharmaceutical development services company, for approximately $25 million.
This acquisition was unanimously approved by the boards of directors of both companies and received the approval of Molecular Profiles’ shareholders. No further approvals are anticipated to be required.
According to the company, Molecular Profiles’ recorded approximately $9 million in revenues for its fiscal year ended July 31, 2013.
Source: Columbia Laboratories
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
